AZTA Stock Recent News
AZTA LATEST HEADLINES
BURLINGTON, Mass. , April 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2025 earnings which ended on March 31, 2025, on Wednesday May 7, 2025, before the market opens.
BURLINGTON, Mass. , March 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, highlighting the Company's ongoing commitment to advancing its strategy and actions aligned with key ESG priorities.
BURLINGTON, Mass. , March 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) announced that Lawrence Y.
Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately.
Azenta, Inc. (NASDAQ:AZTA ) Q1 2025 Earnings Conference Call February 5, 2025 8:30 AM ET Company Participants Yvonne Perron - Vice President, FP&A & Investor Relations John Marotta - President & Chief Executive Officer Lawrence Lin - Executive Vice President & Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens David Saxon - Needham & Company Vijay Kumar - Evercore ISI Matt Stanton - Jefferies Paul Knight - KeyBanc Capital Markets Andrew Cooper - Raymond James Operator Greetings and welcome to the Azenta Q1 2025 Financial Results Conference Call. During the presentation, all participants will be in a listen-only mode.
BURLINGTON, Mass. , Feb. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2024.
BURLINGTON, Mass. , Jan. 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its Board of Directors at its Annual Meeting of Stockholders held earlier today.
BURLINGTON, Mass. , Jan. 27, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2025 earnings which ended on December 31, 2024, on Wednesday February 5, 2025, before the market opens.
BURLINGTON, Mass. , Jan. 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale sample storage in support of the preservation of internationally significant sample collections.
Azenta (AZTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.